Ren, Z., Yuan, J., Tang, B., Lu, Z., Yin, X., Chen, R., Tang, M., Zhang, L., Gan, Y., Huang, L. (2026). Interim analysis of TAD: A phase 2 single-arm open-label study of combination therapy of transarterial chemoembolization and ablation with durvalumab in unresectable hepatocellular carcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e16296